Terms: = Prostate cancer AND FLT3, STK1, 2322, ENSG00000122025, P36888, FLK2, CD135, RP11-153M24_3
57385 results:
1. prostate cancer Foundation Screening Guidelines for Black Men in the United States.
Garraway IP; Carlsson SV; Nyame YA; Vassy JL; Chilov M; Fleming M; Frencher SK; George DJ; Kibel AS; King SA; Kittles R; Mahal BA; Pettaway CA; Rebbeck T; Rose B; Vince R; Winn RA; Yamoah K; Oh WK
NEJM Evid; 2024 May; 3(5):EVIDoa2300289. PubMed ID: 38815168
[TBL] [Abstract] [Full Text] [Related]
2. Impacts of Chlorine 1-3 ıon channels on localized bladder neoplasms.
Muslum O; Ahmet K; Ebru O; Ahmet T; Tunc O; Ahmet K; Irfan O
Cell Mol Biol (Noisy-le-grand); 2024 May; 70(5):76-81. PubMed ID: 38814232
[TBL] [Abstract] [Full Text] [Related]
3. A preliminary study on the reference intervals of serum tumor marker in apparently healthy elderly population in southwestern China using real-world data.
Miao Q; Lei S; Chen F; Niu Q; Luo H; Cai B
BMC Cancer; 2024 May; 24(1):657. PubMed ID: 38811867
[TBL] [Abstract] [Full Text] [Related]
4. Membranous urethral length is the single independent predictor of urinary continence recovery at 12 months following Retzius-sparing robot-assisted radical prostatectomy.
Fonseca J; Moraes-Fontes MF; Sousa I; Oliveira F; Froes G; Gaivão A; Palmas A; Rebola J; Muresan C; Santos T; Dias D; Varandas M; Lopez-Beltran A; Ribeiro R; Fraga A
J Robot Surg; 2024 May; 18(1):230. PubMed ID: 38809307
[TBL] [Abstract] [Full Text] [Related]
5. Comparative analysis of treatment decision-making in patients with localized prostate and cervical cancer: what influences receiving surgery or radiotherapy?
Minamitani M; Katano A; Mukai T; Ohira S; Nakagawa K
Support Care Cancer; 2024 May; 32(6):391. PubMed ID: 38806815
[TBL] [Abstract] [Full Text] [Related]
6. Comparison of ciprofloxacin versus fosfomycin versus fosfomycin plus trimethoprim/sulfamethoxazole for preventing infections after transrectal prostate biopsy.
Bovo A; Kwiatkowski M; Manka L; Wetterauer C; Fux CA; Cattaneo M; Wyler SF; Prause L
World J Urol; 2024 May; 42(1):356. PubMed ID: 38806739
[TBL] [Abstract] [Full Text] [Related]
7. Tumor cells express and maintain HMGB1 in the reduced isoform to enhance CXCR4-mediated migration.
Pirani E; Paparoditis P; Pecoraro M; Danelon G; Thelen M; Cecchinato V; Uguccioni M
Front Immunol; 2024; 15():1358800. PubMed ID: 38803493
[TBL] [Abstract] [Full Text] [Related]
8. Clinicians in the Veterans Health Administration initiate gender-affirming hormone therapy in concordance with clinical guideline recommendations.
Jasuja GK; Wolfe HL; Reisman JI; Vimalananda VG; Rao SR; Blosnich JR; Livingston NA; Shipherd JC
Front Endocrinol (Lausanne); 2024; 15():1086158. PubMed ID: 38800485
[TBL] [Abstract] [Full Text] [Related]
9. Protocol for CHAMPION study: a prospective study of maximal-cytoreductive therapies for patients with de novo metastatic hormone-sensitive prostate cancer who achieve oligopersistent metastases during systemic treatment with apalutamide plus androgen deprivation therapy.
Wang B; Pan J; Zhang T; Ni X; Wei Y; Li X; Fang B; Hu X; Gan H; Wu J; Wang H; Ye D; Zhu Y
BMC Cancer; 2024 May; 24(1):643. PubMed ID: 38796422
[TBL] [Abstract] [Full Text] [Related]
10. Anticancer Effects of the Novel Pyrazolyl-Urea GeGe-3.
Williams A; Cooper E; Clark B; Perry L; Ponassi M; Iervasi E; Brullo C; Greenhough A; Ladomery M
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791418
[TBL] [Abstract] [Full Text] [Related]
11. Discordant Health Implications and Molecular Mechanisms of Vitamin D in Clinical and Preclinical Studies of prostate cancer: A Critical Appraisal of the Literature Data.
Fendler A; Stephan C; Ralla B; Jung K
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791324
[TBL] [Abstract] [Full Text] [Related]
12. Comprehensive Bioinformatic Investigation of TP53 Dysregulation in Diverse cancer Landscapes.
Khan R; Pari B; Puszynski K
Genes (Basel); 2024 Apr; 15(5):. PubMed ID: 38790205
[TBL] [Abstract] [Full Text] [Related]
13. The impact of low pressure pneumoperitoneum in robotic assisted radical prostatectomy II: a prospective, randomized, double blinded trial.
Keating K; Holdren C; Eames R; Pulford C; O'Pry E; Peifer D; Rohloff M; Fletcher J; Maatman TJ
World J Urol; 2024 May; 42(1):347. PubMed ID: 38789638
[TBL] [Abstract] [Full Text] [Related]
14. Dosimetric benefits and preclinical performance of steerable needles in HDR prostate brachytherapy.
de Vries M; Christianen MEMC; Luthart L; de Vries KC; Kolkman-Deurloo IKK; van den Dobbelsteen JJ
Med Eng Phys; 2024 Jun; 128():104177. PubMed ID: 38789214
[TBL] [Abstract] [Full Text] [Related]
15. Waiting Times in prostate cancer Diagnosis and Treatment: A Ten-Year Experience in A Nigerian Teaching Hospital.
Okeke CJ; Jeje EA; Ojewola RW; Ogunjimi MA; Ogbobe UU; Obi AO; Babalola RN
West Afr J Med; 2024 Mar; 41(3):317-321. PubMed ID: 38788158
[TBL] [Abstract] [Full Text] [Related]
16. Novel Metabolites from the Marine-Derived Fungus
Yang B; Shao S; Nie M; Tie Q; Pang X; Lin X; Zhou X; Liu Y; Wang X; Li Y
Mar Drugs; 2024 May; 22(5):. PubMed ID: 38786609
[TBL] [Abstract] [Full Text] [Related]
17. Patient and Family Financial Burden in cancer: A Focus on Differences across Four Provinces, and Reduced Spending Including Decisions to Forego Care in Canada.
Longo CJ; Maity T; Fitch MI; Young JT
Curr Oncol; 2024 May; 31(5):2713-2726. PubMed ID: 38785487
[TBL] [Abstract] [Full Text] [Related]
18. Prognostic value of 17-Gene genomic prostate score in patients with clinically localized prostate cancer: a meta-analysis.
Cui F; Tang X; Man C; Fan Y
BMC Cancer; 2024 May; 24(1):628. PubMed ID: 38783246
[TBL] [Abstract] [Full Text] [Related]
19. The association between three prevalent autoimmune disorders and the likelihood of developing prostate cancer: a Mendelian randomization study.
Deng X; Sun S; Yao W; Yue P; Guo F; Wang Y; Zhang Y
Sci Rep; 2024 May; 14(1):11755. PubMed ID: 38783043
[TBL] [Abstract] [Full Text] [Related]
20. Comparison of quality of life after radical treatment in prostate cancer: radical prostatectomy versus external radiotherapy.
Vera-Álamo L; León-Medina P; Hernández-Flores CN; Armas-Molina JV; Artiles-Hernández JL
Cir Cir; 2024; 92(2):255-263. PubMed ID: 38782388
[TBL] [Abstract] [Full Text] [Related]
[Next]